Close
ACHEMA MIDDLE EAST 2026
17TH Global Drug Delivery & Formulation Summit 2026

News

      Arcos Dorados Continues to Enhance Happy Meal by Offering More Nutritional Foods and Ingredients

      Health & Nutrition
      Arcos Dorados Holdings, Inc , Latin America’s largest restaurant chain and the world’s largest independent McDonald’s franchisee, continues to use its Scale for Good...

      Dynacure Receives Orphan Drug Designation from the US FDA for DYN101 an Antisense Medicine to Treat Rare Disease Centronuclear Myopathies

      FDA Approvals
      Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, announced that the U.S. FDA...

      Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694

      Manufacturing
      Zenith Capital Corp  announced that Zenith Epigenetics Ltd , a wholly-owned subsidiary of Zenith Capital, has entered into a licensing agreement with Newsoara BioPharma...

      Aucta Pharmaceuticals Announces Licensing of Vigabatrin for Oral Solution in China

      Manufacturing
      Aucta Pharmaceuticals, Inc , a technology based company focusing on the development and commercialization of Branded Specialty Products,  announced that the Company has entered...

      Omeros and Lonza Enter Long-Term Manufacturing Agreement for Commercial Supply of Narsoplimab

      Manufacturing
      Omeros Corporation  and Lonza  announced a long-term manufacturing agreement for commercial production of narsoplimab, Omeros’ lead human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2...

      Vesselon Acquires FDA-Approved Lipid Microsphere Drug Imagent For Therapeutic Platform

      FDA Approvals
      Vesselon (www.vesselon.com) an oncology therapeutics company, announced the acquisition of an FDA-approved drug Imagent. Vesselon will use Imagent to create novel therapeutic complexes in...

      Neuropore Therapies and BenevolentAI Enter Strategic Collaboration to Discover Novel Therapeutics Through the Application of Artificial Intelligence

      News
      Neuropore Therapies, Inc. announce that it entered into a collaboration with BenevolentAI to evaluate molecular targets implicated in progressive degenerative diseases which were identified...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.